GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

Search

Hikma Pharmaceuticals PLC

Aperta

SettoreSettore sanitario

1,476 -0.67

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1469

Massimo

1491

Metriche Chiave

By Trading Economics

Entrata

165M

Vendite

41M

1.7B

P/E

Media del settore

10.771

49.052

EPS

1.07

Rendimento da dividendi

5.74

Margine di Profitto

9.698

Dipendenti

9,400

EBITDA

152M

411M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+23.99% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

5.74%

2.36%

Utili prossimi

6 ago 2026

Prossima data del' Ex Dividendo

13 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-526M

3.1B

Apertura precedente

1476.67

Chiusura precedente

1476

Notizie sul Sentiment di mercato

By Acuity

43%

57%

118 / 342 Classifica in Healthcare

Hikma Pharmaceuticals PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Chi Siamo Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat